Baseline bone mineral density testing among breast cancer patients prescribed aromatase inhibitors (AIs).

被引：0
|
作者：
Charlson, John A. [1 ]
Smith, Elizabeth [1 ]
Laud, Purushottam [1 ]
Smallwood, Alicia [1 ]
Neuner, Joan [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6642
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada
    O. L. Tseng
    M. G. Dawes
    J. J. Spinelli
    C. C. Gotay
    M. L. McBride
    Osteoporosis International, 2017, 28 : 3439 - 3449
  • [42] ECHOSOUND TECHNIQUE FOR SHORT-TERM FOLLOW-UP OF THE DENOSUMAB AND AROMATASE INHIBITORS EFFECTS ON BONE MINERAL DENSITY IN BREAST CANCER PATIENTS
    Pisani, P.
    Muratore, M.
    Conversano, F.
    Casciaro, E.
    Forcignano, R.
    Ciccarese, M.
    Surico, G.
    Quarta, L.
    Quarta, E.
    Greco, A.
    De Marco, T.
    Casciaro, S.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S538 - S539
  • [43] Bone mineral density in early breast cancer patients
    Spanik, S.
    Spanikova, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 27 - 32
  • [44] Prior bone health history in breast cancer patients on aromatase inhibitors
    Kwan, Marilyn L.
    Lo, Joan C.
    Tang, Li
    Laurent, Cecile
    Roh, Janise M.
    Chandra, Malini
    Hahn, Theresa E.
    Hong, Chi-Chen
    Sucheston-Campbell, Lara
    Hershman, Dawn L.
    Caan, Bette J.
    Quesenberry, Charles P.
    Sternfeld, Barbara
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Yao, Song
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Management of Bone Health in Breast Cancer Patients Established on Aromatase Inhibitors
    Chan, K.
    Coomaraswamy, W.
    Riddle, P.
    Barkeji, M.
    CLINICAL ONCOLOGY, 2017, 29 (06) : E98 - E98
  • [46] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
  • [47] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Kwan, Marilyn L.
    Yao, Song
    Laurent, Cecile A.
    Roh, Janise M.
    Quesenberry, Charles P., Jr.
    Kushi, Lawrence H.
    Lo, Joan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 523 - 530
  • [48] Prevalence of bone loss among nonmetastatic breast cancer patients treated with aromatase inhibitors in the United States
    Pirolli, M.
    Hernandez, R. K.
    Reich, A.
    Liede, A.
    CANCER RESEARCH, 2016, 76
  • [49] Genetic determinants of bone mineral density loss in Aromatase inhibitors treatment
    Rodriguez-Sanz, Maria
    Prieto-alhambra, Daniel
    Servitja-Tormo, Sonia
    Torres-Del-Pliego, Elisa
    Mellibovsky, Leonardo
    Garrigos, Laia
    Garcia-Giralt, Natalia
    Diez-Perez, Adolfo
    Tusquets, Ignacio
    Nogues, Xavier
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [50] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors (AIs) over time
    Blaes, A. H.
    Petersen, A.
    Beckwith, H.
    Potter, D.
    Florea, N.
    Yee, D.
    Vogel, R.
    Duprez, D.
    CANCER RESEARCH, 2019, 79 (04)
12345